Feiming Tech: China's First VR-Based Cervical Rehabilitation Device Seeks Investment and Distribution Partnerships

Since 1968Virtual Reality TechnologyFrom its inception to the launch of the first commercial virtual reality device in 1991, and now to the widespread application of VR technology in the medical field, rehabilitation technology is undergoing unprecedented transformation. Particularly in pain management, cognitive rehabilitation, and physical therapy, virtual reality technology has brought patients more personalized, precise, and effective rehabilitation training programs, greatly promoting the research and development of rehabilitation medicine.

Currently, China has multipleVirtual Reality Cognitive Rehabilitation Device ProductSuccessfully launched on the market and widely recognized by doctors and patients. Particularly in the field of sports rehabilitation, as an important part of chronic disease treatment, its importance is becoming increasingly prominent. However, the shortage of professional sports rehabilitation talents in China has become a bottleneck restricting the development of this field. Therefore,Digital TransformationBecoming the key to addressing this clinical pain point.

Chengdu Feiming Technology Co., Ltd.(hereinafter referred to as “Feiming Technology”), a high-tech enterprise dedicated to the research and development of innovative medical devices,Pioneering the Integration of Virtual Reality and Computer Vision Technologies, launched "neck exercises" for patients undergoing spinal and neurological rehabilitationAssessment and Rehabilitation Training System.” This system not onlyFills the gap in the domestic market for the application of such technologies, and more for patientsdelivering an unprecedented sports rehabilitation experience. The system received approval as an innovative medical device from Sichuan Province in 2021. In 2024, the product successfully completed clinical trials, a milestone that marks a solid step toward clinical application.

On Thursday, June 6, at 19:30, the 66th session of VCBeat Select New Product Appreciation invitesProfessor & Doctoral Supervisor, West China School of Clinical Medicine, Sichuan UniversityGao Qiang, Wu Lingyun, R&D Director of Feiming Technology, and Zhou Jie, Operations Director of Feiming Technology, present “China's First Neck Movement Assessment and Rehabilitation Training System” product promotion.

Active Medical Devices, Class II; 19 Medical Rehabilitation Equipment - 02 Exercise Rehabilitation Training Equipment

The image shows clinical patients from a research project at West China Hospital of Sichuan University.

"Cervical Motion Assessment and Rehabilitation Training System"is aIntegrated VR Headset with Infrared Depth Camerainnovative medical device products. It can accurately measure the active and passive range of motion, pain levels, and proprioception of the cervical spine, and display the measurement results to physicians. It can guide patients through a series of targeted neck rehabilitation exercises using visual and auditory cues.It provides effective relief solutions for neck pain caused by various conditions, including cervical spondylosis of the neck type, cervical radiculopathy, neck muscle pain, frozen shoulder, and rotator cuff injury.

Measure the active range of motion, passive range of motion, pain level, and proprioception of the cervical spine, and present the measurement results to the physician.

Guide patients through cervical joint mobility exercises, shoulder and neck muscle training, movement speed training, and proprioception training using gamified approaches.

Cervical Spine Rehabilitation Training Method (ZL202010211009.2)

A Method for Determining Whether Real-Time Posture Meets Preset Rules (ZL202011484291.8)

Scan the QR code on the poster to add the assistant and schedule the live broadcast.

Gao Qiang

Professor, Doctoral Supervisor, West China School of Clinical Medicine, Sichuan University

Ph.D. and Postdoctoral Fellow in Rehabilitation Medicine, West China School of Clinical Medicine, Sichuan University; Ph.D. in Rehabilitation Engineering, The Hong Kong Polytechnic University. Currently serves as Deputy Director and Chief Therapist of the Department of Rehabilitation Medicine, West China Hospital, Sichuan University.

Presided over three projects funded by the National Natural Science Foundation of China and two key R&D program projects at the provincial and municipal levels; participated in more than ten national and provincial research projects. Published over 80 academic papers as first or corresponding author, including more than 30 papers indexed by SCI. Served as editor-in-chief or contributing editor for over 20 monographs on rehabilitation medicine.

Clinical and Research Focus: Physical therapy and neuromodulation for neurological disorders, as well as neck, shoulder, waist, and leg pain.

Wu Lingyun

R&D Director, Feiming Technology

Possesses extensive project development experience in the integration of medical devices and artificial intelligence, primarily responsible for technical R&D and project management of the company’s new products.

Zhou Jie

Director of Operations, Chengdu Feiming Technology Co., Ltd.

Research the innovative applications of internet, big data, and artificial intelligence technologies in healthcare; responsible for marketing and operations, and involved in the entire process of planning and implementation of existing products.

Chengdu Feiming Technology Co., Ltd. was established in November 2017, with a registered capital of RMB 30 million. Its core business involves the research and development, manufacturing, and sales of medical devices. Leveraging computer technologies such as artificial intelligence, VR, and big data, the company focuses on musculoskeletal and neurological rehabilitation to develop intelligent rehabilitation medical devices with independent intellectual property rights. It is committed to achieving clinical goals in motor disorder rehabilitation through the integration of human-machine intelligence and active movement.

Virtual reality-based intelligent rehabilitation medical devices primarily target two markets: those dedicated to hospital institutions and those for general home use. The company plans to first establish its presence in the hospital-dedicated market, and then gradually expand into the home-use sector through hospitals and physicians.

“Artery Select New Product Debut” is a live-streaming program under “Artery Select” designed to support healthcare companies in launching innovative products. The program’s mission is: to empower the milestone launch of every medical innovation product.

Scan the QR code below to contact the assistant and reserve a spot for the live stream.

(If already added, please proactively contact the assistant)